MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cerus Corporation - Common Stock (NQ:CERS)

1.800 +0.110 (+6.51%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 16, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cerus Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
News headline image
Cerus Corporation to Participate in Upcoming Investor Conferences
From Cerus Corporation
Via Business Wire
News headline image
Cerus Corporation Announces Third Quarter Financial Results
From Cerus Corporation
Via Business Wire
News headline image
Cerus Corporation Announces Award of U.S. Department of Defense Funding for Development of Pathogen Reduced, Lyophilized Cryoprecipitate
From Cerus Corporation
Via Business Wire
News headline image
Cerus Corporation Announces Health Canada Approval for INTERCEPT Blood System for Platelets with Seven-Day Storage
From Cerus Corporation
Via Business Wire
News headline image
Recap: Cerus Q4 Earnings ↗
Cerus (NASDAQ:CERS) reported its Q4 earnings results on Tuesday, February 22, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Cerus beat... 
Via Benzinga
News headline image
Earnings Scheduled For February 22, 2022 ↗
Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is projected to report quarterly earnings at $0.13 per share on revenue of $439.63 million. • Sohu... 
Via Benzinga
News headline image
Cerus Corporation to Release Third Quarter 2022 Financial Results on November 3, 2022
From Cerus Corporation
Via Business Wire
News headline image
Cerus Corporation Announces Workshop and Abstracts at the 2022 AABB Annual Meeting
From Cerus Corporation
Via Business Wire
News headline image
Cerus Corporation Acknowledges Growing Monkeypox Outbreak and Public Health Emergency
From Cerus Corporation
Via Business Wire
News headline image
Cerus Corporation Announces Another Record Quarter and Reiterates Full Year 2022 Product Revenue Guidance Range
From Cerus Corporation
Via Business Wire
News headline image
Cerus Corporation to Release Second Quarter 2022 Financial Results on August 4, 2022
From Cerus Corporation
Via Business Wire
News headline image
Cerus Corporation Announces Appointment of Hua Shan, MD, PhD to Board of Directors
From Cerus Corporation
Via Business Wire
News headline image
Cerus Corporation Celebrates World Blood Donor Day 2022
From Cerus Corporation
Via Business Wire
News headline image
Class Of 1997: 25 Years Decades After Their IPOs, Where Are These Companies Now? ↗
Delivering on a promise is a tough proposition, and to consistently deliver requires excellence on all fronts. 
Via Benzinga
News headline image
Cerus Corporation Announces First Quarter 2022 Financial Results and Increases Full Year 2022 Product Revenue Guidance Range
From Cerus Corporation
Via Business Wire
News headline image
Cerus Corporation Announces New Manufacturing and Supply Agreement With Fresenius Kabi For INTERCEPT Blood System Sets
From Cerus Corporation
Via Business Wire
News headline image
Cerus Corporation Announces Multi-Year Contract for the INTERCEPT Blood System for Platelets with the American Red Cross
From Cerus Corporation
Via Business Wire
News headline image
Cerus Corporation to Release First Quarter 2022 Financial Results on May 5, 2022
From Cerus Corporation
Via Business Wire
News headline image
Cerus Corporation to Participate at the Cowen 42nd Annual Health Care Conference
From Cerus Corporation
Via Business Wire
News headline image
Cerus's Return On Capital Employed Overview ↗
According to data from Benzinga Pro, during Q4, Cerus's (NASDAQ:CERS) reported sales totaled $39.87 million. Despite a 26.66% increase in earnings, the company posted a loss of $9... 
Via Benzinga
News headline image
Cerus Reports Narrower Quarterly Loss As INTERCEPT Platelet Kits Lift Q4 Sales ↗
Cerus Corp's (NASDAQ: CERS) Q4 FY21 product revenue was $39.9 million, compared to $28.2 million, driven by increased sales of INTERCEPT platelet kits to blood... 
Via Benzinga
News headline image
Cerus Corporation Announces Record Fourth Quarter and Full-Year 2021 Financial Results
From Cerus Corporation
Via Business Wire
News headline image
Cerus Corporation to Release Fourth Quarter and Full-Year 2021 Financial Results on February 22, 2022
From Cerus Corporation
Via Business Wire
News headline image
Cerus Corporation to Participate in Upcoming Virtual Investor Conferences
From Cerus Corporation
Via Business Wire
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
Gainers TCR2 Therapeutics (NASDAQ:TCRR) s... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
Gainers DBV Technologies (NASDAQ:DBVT) sh... 
Via Benzinga
News headline image
Cerus Corporation Announces Record Preliminary Fourth Quarter and Full-Year 2021 Product Revenue and Provides Business Update
From Cerus Corporation
Via Business Wire
News headline image
Uncertain Times ↗
The UK inflation rate last month was 5.1%, not a good omen. 
Via Talk Markets
News headline image
Cerus Corporation to Participate in Stephens Annual Investment Conference
From Cerus Corporation
Via Business Wire
News headline image
Cerus Corporation to Participate in Stifel 2021 Virtual Healthcare Conference
From Cerus Corporation
Via Business Wire
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story